ÂÜÀòÂÒÂ×

Emile Lens is a seasoned executive with extensive experience in leadership roles across various industries. Currently serving as CEO and co-owner of Synexa Life Sciences since October 2019, Emile specializes in biomarker and bioanalytical services for clinical trials and translational studies. Additionally, Emile holds the position of CFO/COO at Avania and co-ownership at Nobilo Ventures, which invests in small and mid-sized companies in the Benelux. Emile's previous roles include Chief Financial Officer at Avania, Factory CRO, Maxeda DIY Group, and a founding partner at Albacore Partners. Emile's finance expertise was further developed at ABN AMRO and MeesPierson, working in mergers and acquisitions and corporate finance. Emile earned an MBA in Business Economics from Erasmus University Rotterdam.